UNIONDALE, N.Y., April 24, 2025 /PRNewswire/ — PrimeRx, a leading provider of pharmacy management systems, has been recognized at the 2025 American Business Awards® with two major honors: the Silver Stevie® Award for Achievement in Product Innovation and the Bronze Stevie® Award for New Product or Service Introduction of the Year. These wins follow a previous Silver Stevie® received earlier this year in the Customer Service category.
The Silver Stevie® for Achievement in Product Innovation highlights PrimeRx’s transformation into a comprehensive, pharmacy-first technology platform. Over the past year, PrimeRx launched several innovative solutions that address key operational challenges for independent pharmacies:
These innovations allow pharmacies to streamline workflows, cut costs, and improve patient care—all within one connected platform.
The Bronze Stevie® for New Product or Service Introduction of the Year recognizes the successful launch of PrimeRx MARKET and PrimeRx CLOUD, which attracted thousands of pharmacy professionals during the campaign. With these releases, PrimeRx became the first pharmacy software provider to embed real-time purchasing directly into its management system, while also offering flexible cloud-based access.
“This recognition underscores our mission to deliver pharmacy-first innovation that meets today’s needs and anticipates tomorrow’s,” said Ketan Mehta, CEO of PrimeRx. “We’re proud to help independent pharmacies stay efficient, profitable, and patient-focused.”
Since 2024, PrimeRx has expanded from a single product into a full ecosystem that enables independent pharmacies to stay competitive and future-ready. Explore PrimeRx Pharmacy Ecosystem here.
About PrimeRx
PrimeRx provides innovative pharmacy management solutions that improve efficiency, ensure compliance, and enhance patient care. Trusted by thousands of pharmacies nationwide, PrimeRx is redefining the future of pharmacy technology. Learn more at www.PrimeRx.io
Media Contact:
Sylvia Mendoza
VP of Marketing, PrimeRx
smendoza@primerx.io | (516) 408‑399
SOURCE PrimeRx
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of…
Oslo, 24 May 2025: Zelluna ASA (the "Company") refers to the resolution by the Company's…
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.…
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon…
INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on…
IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI…